Literature DB >> 9104930

Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update.

A Kampfl1, R M Posmantur, X Zhao, E Schmutzhard, G L Clifton, R L Hayes.   

Abstract

Much recent research has focused on the pathological significance of calcium accumulation in the central nervous system (CNS) following cerebral ischemia, spinal cord injury (SCI), and traumatic brain injury (TBI). Disturbances in neuronal calcium homeostasis may result in the activation of several calcium-sensitive enzymes, including lipases, kinases, phosphatases, and proteases. One potential pathogenic event in a number of acute CNS insults, including TBI, is the activation of the calpains, calcium-activated intracellular proteases. This article reviews new evidence indicating that overactivation of calpains plays a major role in the neurodegenerative cascade following TBI in vivo. Further, this article presents an overview from in vivo and in vitro models of CNS injuries suggesting that administration of calpain inhibitors during the initial 24-h period following injury can attenuate injury-induced derangements of neuronal structure and function. Lastly, this review addresses the potential contribution of other proteases to neuronal damage following TBI.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104930     DOI: 10.1089/neu.1997.14.121

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  36 in total

Review 1.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Head injury, α-synuclein Rep1, and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Sarah A Jewell; Grace S Bhudhikanok; David Umbach; Connie Marras; Robert A Hauser; Joseph Jankovic; Stewart A Factor; Susan Bressman; Kelly E Lyons; Cheryl Meng; Monica Korell; Diana F Roucoux; Jane A Hoppin; Dale P Sandler; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

3.  A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.

Authors:  Stephanie N Thompson; Kimberly M Carrico; Ayman G Mustafa; Mona Bains; Edward D Hall
Journal:  J Neurotrauma       Date:  2010-12       Impact factor: 5.269

4.  Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.

Authors:  Nikita Rudinskiy; Yulia Grishchuk; Anne Vaslin; Julien Puyal; André Delacourte; Harald Hirling; Peter G H Clarke; Ruth Luthi-Carter
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

5.  Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain.

Authors:  Martin Puskarjov; Faraz Ahmad; Kai Kaila; Peter Blaesse
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 6.  Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.

Authors:  Alexander G Yakovlev; Alan I Faden
Journal:  NeuroRx       Date:  2004-01

7.  A novel strategy to activate cytoprotective genes in the injured brain.

Authors:  Jing Zhao; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Biochem Biophys Res Commun       Date:  2011-03-22       Impact factor: 3.575

8.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

Review 9.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

10.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.